当前位置： SCI文献检索 > Orphanet Journal of Rare Diseases期刊下所有文献 > Hermansky-Pudlak syndrome and oculocutaneous albinism in Chinese children with pigmentation defects and easy bruising.

Hermansky-Pudlak syndrome and oculocutaneous albinism in Chinese children with pigmentation defects and easy bruising.

Abstract：

BACKGROUND:Determining the etiology of oculocutaneous albinism is important for proper clinical management and to determine prognosis. The purpose of this study was to genotype and phenotype eight adopted Chinese children who presented with oculocutaneous albinism and easy bruisability. RESULTS:The patients were evaluated at a single center; their ages ranged from 3 to 8 years. Whole exome or direct sequencing showed that two of the children had Hermansky-Pudlak syndrome (HPS) type-1 (HPS-1), one had HPS-3, one had HPS-4, and four had non-syndromic oculocutaneous albinism associated with TYR variants (OCA1). Two frameshift variants in HPS1 (c.9delC and c.1477delA), one nonsense in HPS4 (c.416G > A), and one missense variant in TYR (c.1235C > T) were unreported. The child with HPS-4 is the first case with this subtype reported in the Chinese population. Hypopigmentation in patients with HPS was mild compared to that in OCA1 cases, who had severe pigment defects. Bruises, which may be more visible in patients with hypopigmentation, were found in all cases with either HPS or OCA1. Whole mount transmission electron microscopy demonstrated absent platelet dense granules in the HPS cases; up to 1.9 mean dense granules per platelet were found in those with OCA1. Platelet aggregation studies in OCA1 cases were inconclusive. CONCLUSIONS:Clinical manifestations of oculocutaneous albinism and easy bruisability may be observed in children with HPS or OCA1. Establishing definitive diagnoses in children presenting with these phenotypic features is facilitated by genetic testing. Non-syndromic oculocutaneous albinism and various HPS subtypes, including HPS-4, are found in children of Chinese ancestry.

journal_name

Orphanet J Rare Dis

journal_title

Orphanet journal of rare diseases

authors

Power B,Ferreira CR,Chen D,Zein WM,O'Brien KJ,Introne WJ,Stephen J,Gahl WA,Huizing M,Malicdan MCV,Adams DR,Gochuico BR

doi

10.1186/s13023-019-1023-7

subject

Has Abstract

pub_date

2019-02-21 00:00:00

pages

52

issue

1

issn

1750-1172

pii

10.1186/s13023-019-1023-7

journal_volume

14

pub_type

杂志文章

相关文献

Orphanet Journal of Rare Diseases文献大全
  • Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency.

    abstract：BACKGROUND:The activation of plasma enzyme systems contributes to hereditary angioedema attacks. We aimed to study the activation markers of the fibrinolytic, coagulation, and contact systems in a larger number of paired samples obtained from the same C1-INH-HAE patients in symptom-free periods and during attacks. MET...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-015-0351-5

    authors： Csuka D,Veszeli N,Imreh É,Zotter Z,Skopál J,Prohászka Z,Varga L,Farkas H

    更新日期：2015-10-09 00:00:00

  • A new UHPLC-MS/MS method for the screening of urinary oligosaccharides expands the detection of storage disorders.

    abstract：BACKGROUND:Oligosaccharidoses are storage disorders due to enzymatic defects involved in the breakdown of the oligosaccharidic component of glycosylated proteins. The defect cause the accumulation of oligosaccharides (OS) and, depending on the lacking enzyme, results in characteristic profiles which are helpful for the...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-020-01662-8

    authors： Semeraro M,Sacchetti E,Deodato F,Coşkun T,Lay I,Catesini G,Olivieri G,Rizzo C,Boenzi S,Dionisi-Vici C

    更新日期：2021-01-09 00:00:00

  • Haploidentical stem cell transplantation in two children with mucopolysaccharidosis VI: clinical and biochemical outcome.

    abstract：BACKGROUND:Mucopolysaccharidosis VI (MPS VI) is an autosomal recessive progressive multiorgan disorder due to mutation in the gene encoding the enzyme Arylsulfatase B (ARSB). Dysfunctional ARSB causes lysosomal accumulation of glycosaminoglycans (GAG). Currently, enzyme replacement therapy (ERT) is preferred to hematop...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/1750-1172-8-134

    authors： Jester S,Larsson J,Eklund EA,Papadopoulou D,Månsson JE,Békássy AN,Turkiewicz D,Toporski J,Øra I

    更新日期：2013-09-05 00:00:00

  • Progressive familial intrahepatic cholestasis.

    abstract：:Progressive familial intrahepatic cholestasis (PFIC) refers to heterogeneous group of autosomal recessive disorders of childhood that disrupt bile formation and present with cholestasis of hepatocellular origin. The exact prevalence remains unknown, but the estimated incidence varies between 1/50,000 and 1/100,000 bir...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章,评审

    doi：10.1186/1750-1172-4-1

    authors： Davit-Spraul A,Gonzales E,Baussan C,Jacquemin E

    更新日期：2009-01-08 00:00:00

  • The impact of Hunter syndrome (mucopolysaccharidosis type II) on health-related quality of life.

    abstract：BACKGROUND:Hunter syndrome (mucopolysaccharidosis type II (MPS II)) is a rare metabolic disease that can severely compromise health, well-being and life expectancy. Little evidence has been published on the impact of MPS II on health-related quality of life (HRQL). The objective of this study was to describe this impac...

    journal_title：Orphanet journal of rare diseases

    pub_type： 临床试验,杂志文章

    doi：10.1186/1750-1172-8-101

    authors： Raluy-Callado M,Chen WH,Whiteman DA,Fang J,Wiklund I

    更新日期：2013-07-10 00:00:00

  • Quality of life of children with spinal muscular atrophy and their caregivers from the perspective of caregivers: a Chinese cross-sectional study.

    abstract：BACKGROUND:Spinal muscular atrophy (SMA) is an autosomal-recessive motor neuron disease leading to dysfunction of multiple organs. SMA can impair the quality of life (QoL) of patients and family. We aimed to evaluate the QoL of children with SMA and their caregivers and to identify the factors associated with QoL in a ...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-020-01638-8

    authors： Yao M,Ma Y,Qian R,Xia Y,Yuan C,Bai G,Mao S

    更新日期：2021-01-06 00:00:00

  • The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study.

    abstract：BACKGROUND:X-linked hypophosphataemia (XLH) is a rare, hereditary, progressive and lifelong phosphate wasting disorder characterised by pathological elevations in fibroblast growth factor (FGF) 23 concentration and activity; XLH has an incidence of approximately 1 in 20-25,000 individuals. Excess FGF23 activity leads t...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-020-01434-4

    authors： Padidela R,Nilsson O,Makitie O,Beck-Nielsen S,Ariceta G,Schnabel D,Brandi ML,Boot A,Levtchenko E,Smyth M,Jandhyala R,Mughal Z

    更新日期：2020-06-30 00:00:00

  • Correction to: Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome - new data and literature review.

    abstract：:After publication of this article [1], it is noticed reference no. 17 was incorrectly provided, details are shown below. ...

    journal_title：Orphanet journal of rare diseases

    pub_type： 已发布勘误

    doi：10.1186/s13023-019-1084-7

    authors： Pittaway JFH,Harrison C,Rhee Y,Holder-Espinasse M,Fryer AE,Cundy T,Drake WM,Irving MD

    更新日期：2019-05-10 00:00:00

  • Clinical and endocrine characteristics and genetic analysis of Korean children with McCune-Albright syndrome: a retrospective cohort study.

    abstract：BACKGROUND:McCune-Albright syndrome (MAS) is a rare disease defined by the triad of fibrous dysplasia (FD), café au lait spots, and peripheral precocious puberty (PP). Because of the rarity of this disease, only a few individuals with MAS have been reported in Korea. We describe the various clinical and endocrine manif...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-016-0496-x

    authors： Cho EK,Kim J,Yang A,Ki CS,Lee JE,Cho SY,Jin DK

    更新日期：2016-08-09 00:00:00

  • Clinical burden of illness in patients with phenylketonuria (PKU) and associated comorbidities - a retrospective study of German health insurance claims data.

    abstract：BACKGROUND:Phenylketonuria (PKU) is an inherited deficiency in the enzyme phenylalanine hydroxylase (PAH), which, when poorly-managed, is associated with clinical features including deficient growth, microcephaly, seizures, and intellectual impairment. The management of PKU should start as soon as possible after diagno...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-019-1153-y

    authors： Trefz KF,Muntau AC,Kohlscheen KM,Altevers J,Jacob C,Braun S,Greiner W,Jha A,Jain M,Alvarez I,Lane P,Schröder C,Rutsch F

    更新日期：2019-07-22 00:00:00

  • Patient and caregiver perspectives on guideline adherence: the case of endocrine and bone health recommendations for Duchenne muscular dystrophy.

    abstract：BACKGROUND:Clinical care guidelines are typically developed by clinicians and researchers. Including patient and caregiver voices in guideline development may help create guidelines that are more useful for patients and consequently improve their guideline adherence. Although there is substantial research on the factor...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-019-1173-7

    authors： Denger B,Kinnett K,Martin A,Grant S,Armstrong C,Khodyakov D

    更新日期：2019-08-20 00:00:00

  • European principles of inhibitor management in patients with haemophilia.

    abstract：BACKGROUND:In spite of recent major advances in the understanding and treatment of inhibitor development in patients with haemophilia, multidisciplinary management of many of these patients remains suboptimal and highly heterogenous across Europe. METHODS:Following a series of multidisciplinary meetings and a review o...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章,评审

    doi：10.1186/s13023-018-0800-z

    authors： Giangrande PLF,Hermans C,O'Mahony B,de Kleijn P,Bedford M,Batorova A,Blatný J,Jansone K,European Haemophilia Consortium (EHC) and the European Association for Haemophilia and Allied Disorders (EAHAD).

    更新日期：2018-04-27 00:00:00

  • Parents' experiences of living with, and caring for children, adolescents and young adults with Mucopolysaccharidosis (MPS).

    abstract：BACKGROUND:Many rare diseases of childhood are life-threatening and chronically debilitating, so living with a rare disease is an on-going challenge for patients and their families. MPS is one of a range of rare inherited metabolic disorders (IMDs) that come under category 3 of life-limiting conditions, where there is ...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-016-0521-0

    authors： Somanadhan S,Larkin PJ

    更新日期：2016-10-10 00:00:00

  • Syndromic (phenotypic) diarrhea in early infancy.

    abstract：:Syndromic diarrhea (SD), also known as phenotypic diarrhea (PD) or tricho-hepato-enteric syndrome (THE), is a congenital enteropathy presenting with early-onset of severe diarrhea requiring parenteral nutrition (PN). To date, no epidemiological data are available. The estimated prevalence is approximately 1/300,000-40...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章,评审

    doi：10.1186/1750-1172-3-6

    authors： Goulet O,Vinson C,Roquelaure B,Brousse N,Bodemer C,Cézard JP

    更新日期：2008-02-28 00:00:00

  • Drug development for exceptionally rare metabolic diseases: challenging but not impossible.

    abstract：BACKGROUND:We studied to what extent the level of scientific knowledge on exceptionally rare metabolic inherited diseases and their potential orphan medicinal products is associated with sponsors deciding to apply for an orphan designation at the US Food and Drug Administration (FDA) or the European Medicines Agency (E...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/1750-1172-8-179

    authors： Putzeist M,Mantel-Teeuwisse AK,Wied CC,Hoes AW,Leufkens HG,de Vrueh RL

    更新日期：2013-11-15 00:00:00

  • Thymectomy for non-thymomatous myasthenia gravis: a propensity score matched study.

    abstract：BACKGROUND:The efficacy of thymectomy in patients with non-thymomatous Myasthenia Gravis (MG) is still unclear. Main limitations have been variable outcome definitions, lack of a control group and adjustment for confounding. OBJECTIVE:To study the efficacy of thymectomy in achieving remission or minimal manifestation ...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-014-0214-5

    authors： Barnett C,Katzberg HD,Keshavjee S,Bril V

    更新日期：2014-12-24 00:00:00

  • Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease.

    abstract：:Taliglucerase alfa is an enzyme replacement therapy (ERT) approved for treatment of adult and paediatric patients with Type 1 Gaucher disease (GD) in several countries and the first plant cell-expressed recombinant therapeutic protein approved by the US Food and Drug Administration for humans. Here, we review the find...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章,评审

    doi：10.1186/s13023-018-0776-8

    authors： Zimran A,Wajnrajch M,Hernandez B,Pastores GM

    更新日期：2018-02-23 00:00:00

  • Neuropsychological and neuroanatomical phenotype in 17 patients with cystinosis.

    abstract：BACKGROUND:Cystinosis is a rare autosomal recessive disorder caused by intracellular cystine accumulation. Proximal tubulopathy (Fanconi syndrome) is one of the first signs, leading to end-stage renal disease between the age of 12 and 16. Other symptoms occur later and encompass endocrinopathies, distal myopathy and de...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-019-1271-6

    authors： Curie A,Touil N,Gaillard S,Galanaud D,Leboucq N,Deschênes G,Morin D,Abad F,Luauté J,Bodenan E,Roche L,Acquaviva C,Vianey-Saban C,Cochat P,Cotton F,Bertholet-Thomas A

    更新日期：2020-02-26 00:00:00

  • Nerve ultrasound characterizes AMN polyneuropathy as inhomogeneous and focal hypertrophic.

    abstract：OBJECTIVE:High-resolution nerve ultrasound (HRUS) is a painless tool to quickly evaluate peripheral nerve morphology in vivo. This study set out to characterize peripheral nerve involvement in X-linked adrenomyeloneuropathy (AMN) by HRUS. METHODS:Thirteen adults with genetically proven AMN were examined using the Ultr...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-018-0939-7

    authors： Rattay TW,Just J,Röben B,Hengel H,Schüle R,Synofzik M,Söhn AS,Winter N,Dammeier N,Schöls L,Grimm A

    更新日期：2018-11-03 00:00:00

  • Ocular lesions in hereditary hemorrhagic telangiectasia: genetics and clinical characteristics.

    abstract：BACKGROUND:The aim of our study is to study the association between eye lesions in Hereditary Hemorrhagic Telangiectasia (HHT) and other signs of the disease, as well as to characterize its genetics. METHODS:A cross-sectional study was conducted of a cohort of 206 patients studied in the HHT Unit of Hospital de Sierra...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-020-01433-5

    authors： Gómez-Acebo I,Prado SR,De La Mora Á,Puente RZ,de la Roza Varela B,Dierssen-Sotos T,Llorca J

    更新日期：2020-06-29 00:00:00

  • High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study.

    abstract：BACKGROUND:Hepatic macrophage (Kupffer cell) hyperplasia is often described in Wilson's disease (WD). In many liver diseases, Kupffer cell activation is related to disease severity, liver function, and fibrosis but the importance in WD is unknown. Kupffer cell activation can be assessed by the P-concentration of solubl...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-018-0910-7

    authors： Björklund J,Laursen TL,Sandahl TD,Møller HJ,Vilstrup H,Ott P,Grønbæk H

    更新日期：2018-09-21 00:00:00

  • Krüppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency.

    abstract：BACKGROUND:Chronic obstructive pulmonary disease (COPD) is influenced by environmental and genetic factors. An important fraction of COPD cases harbor a major genetic determinant, inherited ZZ (Glu342Lys) α1-antitrypsin deficiency (AATD). A study was undertaken to investigate gene expression patterns in end-stage COPD ...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/1750-1172-7-29

    authors： Koczulla AR,Jonigk D,Wolf T,Herr C,Noeske S,Klepetko W,Vogelmeier C,von Neuhoff N,Rische J,Wrenger S,Golpon H,Voswinckel R,Luisetti M,Ferrarotti I,Welte T,Janciauskiene S

    更新日期：2012-05-23 00:00:00

  • A nationwide survey on Marinesco-Sjögren syndrome in Japan.

    abstract：BACKGROUND:Marinesco-Sjögren syndrome (MSS) is an autosomal recessive multisystem disorder characterized by the tetralogy of cerebellar ataxia, congenital cataracts, intellectual disability, and progressive muscle weakness due to myopathy. MSS is extremely rare, and its clinical, pathological, and genetic features are ...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/1750-1172-9-58

    authors： Goto M,Okada M,Komaki H,Sugai K,Sasaki M,Noguchi S,Nonaka I,Nishino I,Hayashi YK

    更新日期：2014-04-23 00:00:00

  • Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial.

    abstract：BACKGROUND:X-linked Duchenne muscular dystrophy (DMD), the most frequent human hereditary skeletal muscle myopathy, inevitably leads to progressive dilated cardiomyopathy. We assessed the effect and safety of a combined treatment with the ACE-inhibitor enalapril and the β-blocker metoprolol in a German cohort of infant...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章,随机对照试验

    doi：10.1186/s13023-019-1066-9

    authors： Dittrich S,Graf E,Trollmann R,Neudorf U,Schara U,Heilmann A,von der Hagen M,Stiller B,Kirschner J,Pozza RD,Müller-Felber W,Weiss K,von Au K,Khalil M,Motz R,Korenke C,Lange M,Wilichowski E,Pattathu J,Ebinger F,Wiec

    更新日期：2019-05-10 00:00:00

  • Correction to: Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes.

    abstract：:The original version of this article [1] unfortunately included an error to an author's name. Author Maja Di Rocco was erroneously presented as Maja DiRocco.The correct author name has been included in the author list of this Correction article and is already updated in the original article. ...

    journal_title：Orphanet journal of rare diseases

    pub_type： 已发布勘误

    doi：10.1186/s13023-019-1096-3

    authors： Pignolo RJ,Baujat G,Brown MA,De Cunto C,Di Rocco M,Hsiao EC,Keen R,Al Mukaddam M,Sang KLQ,Wilson A,White B,Grogan DR,Kaplan FS

    更新日期：2019-05-23 00:00:00

  • Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability.

    abstract：BACKGROUND:A pattern of major and minor congenital anomalies, facial dysmorphic features, and neurodevelopmental difficulties, including cognitive and social impairments has been reported in some children exposed to sodium valproate (VPA) during pregnancy. Recognition of the increased risks of in utero exposure to VPA ...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-019-1064-y

    authors： Clayton-Smith J,Bromley R,Dean J,Journel H,Odent S,Wood A,Williams J,Cuthbert V,Hackett L,Aslam N,Malm H,James G,Westbom L,Day R,Ladusans E,Jackson A,Bruce I,Walker R,Sidhu S,Dyer C,Ashworth J,Hindley D,Diaz G

    更新日期：2019-07-19 00:00:00

  • Alpha-1 antitrypsin deficiency: outstanding questions and future directions.

    abstract：BACKGROUND:Alpha-1 antitrypsin deficiency (AATD) is a rare hereditary condition that leads to decreased circulating alpha-1 antitrypsin (AAT) levels, significantly increasing the risk of serious lung and/or liver disease in children and adults, in which some aspects remain unresolved. METHODS:In this review, we summar...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章,评审

    doi：10.1186/s13023-018-0856-9

    authors： Torres-Durán M,Lopez-Campos JL,Barrecheguren M,Miravitlles M,Martinez-Delgado B,Castillo S,Escribano A,Baloira A,Navarro-Garcia MM,Pellicer D,Bañuls L,Magallón M,Casas F,Dasí F

    更新日期：2018-07-11 00:00:00

  • The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy.

    abstract：BACKGROUND:The TUBA1A-associated tubulinopathy is clinically heterogeneous with brain malformations, microcephaly, developmental delay and epilepsy being the main clinical features. It is an autosomal dominant disorder mostly caused by de novo variants in TUBA1A. RESULTS:In three individuals with developmental delay w...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章,评审

    doi：10.1186/s13023-019-1020-x

    authors： Hebebrand M,Hüffmeier U,Trollmann R,Hehr U,Uebe S,Ekici AB,Kraus C,Krumbiegel M,Reis A,Thiel CT,Popp B

    更新日期：2019-02-11 00:00:00

  • Best practice guidelines for management of spinal disorders in skeletal dysplasia.

    abstract：BACKGROUND:Disorders of the spine present a common and difficult management concern in patients with skeletal dysplasia. Due to the rarity of these conditions however, the literature, largely consisting of small, single institution case series, is sparse in regard to well-designed studies to support clinical decision m...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-020-01415-7

    authors： White KK,Bober MB,Cho TJ,Goldberg MJ,Hoover-Fong J,Irving M,Kamps SE,Mackenzie WG,Raggio C,Spencer SA,Bompadre V,Savarirayan R,Skeletal Dysplasia Management Consortium.

    更新日期：2020-06-24 00:00:00

  • Patients with ACVR1R206H mutations have an increased prevalence of cardiac conduction abnormalities on electrocardiogram in a natural history study of Fibrodysplasia Ossificans Progressiva.

    abstract：BACKGROUND:Genetic contributors to cardiac arrhythmias are often found in cardiovascular conduction pathways and ion channel proteins. Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare disease of massive heterotopic ossification caused by a highly recurrent R206H mutation in ACVR1/ALK2. This mutation causes ...

    journal_title：Orphanet journal of rare diseases

    pub_type： 杂志文章

    doi：10.1186/s13023-020-01465-x

    authors： Kou S,De Cunto C,Baujat G,Wentworth KL,Grogan DR,Brown MA,Di Rocco M,Keen R,Al Mukaddam M,le Quan Sang KH,Masharani U,Kaplan FS,Pignolo RJ,Hsiao EC

    更新日期：2020-07-29 00:00:00